Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Prolonged Molecular and Clinical Remissions in Follicular Lymphoma Patients Treated with HDT/ASCT and Combination Immunotherapy with Rituximab and Interferon α

Liam Smyth, MD FRCPath, Rena Buckstein, MD FRCPC, Pennell Nancy, BSc, Rashmi Weerasinghe, Matthew Cheung, MD MS, FRCP, Eugenia Piliotis, MD FRCP, MD, Kevin Imrie, MD, David Spaner, MD PhD, Marciano D. Reis, MD, Lisa Chodirker, MD, Zeina Ghorab, Violet ruth,nancy Milliken, Angela Boudreau, RN, BScN, MN, CON(C), Neil Berinstein, MD

Blood (2017) 130 (Supplement 1): 4069.

https://doi.org/10.1182/blood.V130.Suppl_1.4069.4069

Published: 2017

Journal Articles

Risk Adjusted Management of Newly Diagnosed High and Intermediate FLIPI Follicular Lymphoma Using (90)Y Ibritumomab Tiuxetan

Neil L Berinstein, MD, Nancy M Pennell, BSc, Rashmi Weerasinghe, Matthew C. Cheung, MD SM, FRCPC, Eugenia Piliotis, MD FRCP, MD, Kevin R Imrie, MD, Mary-Anne Cussen, Rena Buckstein, MD, Zeina Ghorab, Ellen Miles, Marciano D. Reis, MD

Blood (2016) 128 (22): 1794.

https://doi.org/10.1182/blood.V128.22.1794.1794

Published: 2016

Journal Articles

Sensory Neuropeptides Prime the Splenic Marginal Zone for Optimal Humoral Immunity

Hubert Tsui, MD PhD, Magar Ghazarian, BSc, Shawn Winer, MD MSC, PhD, Hibret Adissu, DVM, DVSc, PhD, Michael Dosch, MD PhD, Marciano D. Reis, MD FRCPC, Daniel Winer, MD, Armand Keating, MD

Blood (2014) 124 (21): 4123.

https://doi.org/10.1182/blood.V124.21.4123.4123

Published: 2014

Journal Articles

NR2F6 (EAR-2) Is a Novel Leukemia Oncogene Whose Cellular Function Is to Regulate Terminal Differentiation of Erythrocytes at the Proerythroblast Stage

Christine Victoria Ichim, PhD, Dzana Dervovic, PhD, David Koos, PhD, Marciano D. Reis, MD, Alden Chesney, MD FRCPC, Richard A. Wells, MD DPhil

Blood (2014) 124 (21): 1337.

https://doi.org/10.1182/blood.V124.21.1337.1337

Published: 2014

Journal Articles

The Effects of Azacitidine on Quality of Life Measured Longitudinally In MDS Patients Treated at a Tertiary Care Center

Sarah A. Ingber, MD, Kim Thompson, Adam Lam, Alex Mamedov, Liying Zhang, PhD, Alibhai Shabbir, MD, David Good, MD, Alden Chesney, MD, Marciano D. Reis, MD, Matthew Cheung, MD, Vicky Harris, RN, Richard A. Wells, MD, DPhil, Rena Buckstein, MD

Blood (2010) 116 (21): 2571.

https://doi.org/10.1182/blood.V116.21.2571.2571

Published: 2010

Journal Articles

Arginase and YKL-40, Effectors of Immunosuppressive Myeloid Cells, Are Over-Expressed In the Bone Marrow of Most Chronic Myelomonocytic Leukemia Patients, and Are Potential Prognostic Biomarkers In Myelodysplastic Syndrome

Michael J. Rauh, MD, PhD, Deeksha Mahendru, BSc, Roman Shapiro, BSc, Alden Chesney, MD, David Good, MD, Marciano D. Reis, MD, Adam Lam, Gerald Krystal, PhD, Rena Buckstein, MD, FRCPC, Richard A. Wells, MD, DPhil

Blood (2010) 116 (21): 1855.

https://doi.org/10.1182/blood.V116.21.1855.1855

Published: 2010

Journal Articles

Stromal Cell-Derived Secreted Factors Contribute to the Innate Imatinib Resistance of Leukemia Stem Cells In a Genetically Defined Murine Model of Chronic Myeloid Leukemia Blast Crisis

C. Ronald Geyer, Michael Szeto, Ashton Craven, Marciano D. Reis, David P. Sheridan, John F. DeCoteau

Blood (2010) 116 (21): 204.

https://doi.org/10.1182/blood.V116.21.204.204

Published: 2010

Journal Articles

The Addition of Rituximab and/or Alpha-Interferon to High Dose Chemotherapy and Autologous Stem Cell Transplantation for Patients with Relapsed Follicular Lymphoma Produces Durable Progression Free Survival and Molecular Remissions

Sita Bhella, MD, Neil L Berinstein, MD, FRCPC, Nancy Pennell, BSc, Matthew Cheung, MD, FRCPC, Kevin R. Imrie, MD, FRCPC, Violet Miliken, Marciano D. Reis, MD, FRCPC, Alden Chesney, MD, FRCPC, David Good, MD, FRCPC, Lisa Hicks, MD, MSc, FRCPC, Eugenia Piliotis, MD, FRCPC, Michael Crump, MD, FRCPC, Rena Buckstein, MD, FRCPC

Blood (2010) 116 (21): 1357.

https://doi.org/10.1182/blood.V116.21.1357.1357

Published: 2010

Journal Articles

Genetic Screen to Isolate “Lariat” Peptides for Characterizing ABL Kinase Activity and Conformation

V.M. Bharathikumar, Kris Barreto, Marciano D. Reis, MD, John F. Decoteau, MD, C. Ronald Geyer

Blood (2010) 116 (21): 438.

https://doi.org/10.1182/blood.V116.21.438.438

Published: 2010

Journal Articles

Validation of a Scoring System to Establish the Pretest Probability of Myelodysplastic Syndrome in Patients with Unexplained Cytopenias or Macrocytosis.

Jennifer Rauw, BSc, MD, Richard A. Wells, MD, DPhil, Alden Chesney, II, MD, Marciano D. Reis, MD, Rena Buckstein, MD, FRCPC

Blood (2009) 114 (22): 1761.

https://doi.org/10.1182/blood.V114.22.1761.1761

Published: 2009

Journal Articles

Iron Overload and Haematopoiesis in MDS: Does Blood Transfusion Promote Progression to AML?

Lap Shu Alan Chan, Rena Buckstein, MD, Marciano D. Reis, MD, Alden Chesney, II, MD, Adam Lam, Matthew C Cheung, MD, Eugenia Piliotis, MD, Lilly Chunhong Gu, MD, PhD, Richard A. Wells, MD, DPhil

Blood (2008) 112 (11): 2685.

https://doi.org/10.1182/blood.V112.11.2685.2685

Published: 2008

Journal Articles

Hypogammaglobulinemia Following Rituximab and High-Dose Therapy and Autologous Stem-Cell Transplant: Incidence and Predictors of Prolonged Immunoglobulin Deficiencies

Nancy Pennell, Matthew Cheung, MD SM, FRCP, Lisa K Hicks, MD, MSc, Rena Buckstein, MD, FRCPC, Kevin R Imrie, MD, Eugenia Piliotis, MD, David Spaner, Zeina Ghorab, Marciano D. Reis, MD, Violet Milliken, Angela Boudreau, Neil Berinstein, MD

Blood (2008) 112 (11): 4351.

https://doi.org/10.1182/blood.V112.11.4351.4351

Published: 2008

Journal Articles

NR2F6 Initiates Myelodysplasia and Acute Leukemia by Promoting Stem Cell Self-Renewal

Christine V. Ichim, MSc, Marciano D. Reis, MD, Alden Chesney, II, MD, Gisele Knowles, MSc, Norman N. Iscove, MD, PhD, Richard A. Wells, MD, DPhil

Blood (2008) 112 (11): 3655.

https://doi.org/10.1182/blood.V112.11.3655.3655

Published: 2008

Journal Articles

NR2F6, the Mammalian Homologue of Drosophila Seven Up, Can Initiate Myelodysplasia and Acute Leukemia.

Christine V. Ichim, MSc, Alden Chesney, MD, Marciano D. Reis, MD, Norman N. Iscove, MD, PhD, Richard A. Wells, MD, DPhil

Blood (2007) 110 (11): 400.

https://doi.org/10.1182/blood.V110.11.400.400

Published: 2007

Journal Articles

Estimating the Prevalence of Myelodysplasia: A Retrospective Review of Bone Marrow Histopathology in 322 Cases of Unexplained Cytopenia(s) in a Teaching Hospital.

K. Jang, HBSc, Richard A. Wells, MD PhD, Alden Chesney, MD, Marciano D. Reis, MD, J. Friedlich, L. Zhang, MSc, Rena Buckstein, MD

Blood (2006) 108 (11): 2613.

https://doi.org/10.1182/blood.V108.11.2613.2613

Published: 2006

Journal Articles

Rituximab Increases Response to ESHAP in Relapsed, Refractory, and Transformed Aggressive B-Cell Lymphoma.

Lisa Hicks, Rena Buckstein, Joy Mangel, Eugenia Piliotis, Kevin Imrie, Matthew C. Cheung, David E. Spaner, Marciano D. Reis, Zeina Ghorab, Violet Milliken, Nancy Pennell, Neil Berinstein

Blood (2006) 108 (11): 3067.

https://doi.org/10.1182/blood.V108.11.3067.3067

Published: 2006

NARROW

Prolonged Molecular and Clinical Remissions in Follicular Lymphoma Patients Treated with HDT/ASCT and Combination Immunotherapy with Rituximab and Interferon α

Risk Adjusted Management of Newly Diagnosed High and Intermediate FLIPI Follicular Lymphoma Using (90)Y Ibritumomab Tiuxetan

Sensory Neuropeptides Prime the Splenic Marginal Zone for Optimal Humoral Immunity

NR2F6 (EAR-2) Is a Novel Leukemia Oncogene Whose Cellular Function Is to Regulate Terminal Differentiation of Erythrocytes at the Proerythroblast Stage

The Effects of Azacitidine on Quality of Life Measured Longitudinally In MDS Patients Treated at a Tertiary Care Center

Arginase and YKL-40, Effectors of Immunosuppressive Myeloid Cells, Are Over-Expressed In the Bone Marrow of Most Chronic Myelomonocytic Leukemia Patients, and Are Potential Prognostic Biomarkers In Myelodysplastic Syndrome

Stromal Cell-Derived Secreted Factors Contribute to the Innate Imatinib Resistance of Leukemia Stem Cells In a Genetically Defined Murine Model of Chronic Myeloid Leukemia Blast Crisis

The Addition of Rituximab and/or Alpha-Interferon to High Dose Chemotherapy and Autologous Stem Cell Transplantation for Patients with Relapsed Follicular Lymphoma Produces Durable Progression Free Survival and Molecular Remissions

Genetic Screen to Isolate “Lariat” Peptides for Characterizing ABL Kinase Activity and Conformation

Validation of a Scoring System to Establish the Pretest Probability of Myelodysplastic Syndrome in Patients with Unexplained Cytopenias or Macrocytosis.

Iron Overload and Haematopoiesis in MDS: Does Blood Transfusion Promote Progression to AML?

Hypogammaglobulinemia Following Rituximab and High-Dose Therapy and Autologous Stem-Cell Transplant: Incidence and Predictors of Prolonged Immunoglobulin Deficiencies

NR2F6 Initiates Myelodysplasia and Acute Leukemia by Promoting Stem Cell Self-Renewal

NR2F6, the Mammalian Homologue of Drosophila Seven Up, Can Initiate Myelodysplasia and Acute Leukemia.

Estimating the Prevalence of Myelodysplasia: A Retrospective Review of Bone Marrow Histopathology in 322 Cases of Unexplained Cytopenia(s) in a Teaching Hospital.

Rituximab Increases Response to ESHAP in Relapsed, Refractory, and Transformed Aggressive B-Cell Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only